Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,001–1,100 of 2,883
Effects of senescence on the tumour microenvironment and response to therapy
Reynolds, L. E., Maallin, S., Haston, S., Martínez-Barberá, J. P., Hodivala‐Dilke, K., & Pedrosa, A. (2023) · FEBS Journal · doi:10.1111/febs.16984 · Cited by 45
“Deletion of p16 Ink4a and p21 Cip1/Waf1 reduces the expression of CX3CR1, preventing myeloid-derived suppressive cells from accumulating in the tissue, increasing the lifespan of mice and alleviating age-related diseases such as cancer [41].”
LncRNAs regulating stemness in aging
Sousa‐Franco, A., Rebelo, K., da Rocha, S. T., & de Jesus, B. B. (2018) · Aging Cell · doi:10.1111/acel.12870 · Cited by 43
Conte, T. C., Duran-Bishop, G., Orfi, Z., Mokhtari, I., Deprez, A., Côté, I., Molina, T., Taeyeon, K., Tellier, L., Roussel, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39663-3 · Cited by 47
“Pioneer studies showed thatgeneticremovalofsenescentcellsexpressingthecellcycleinhibitor p16 in aging mice enhances their lifespan 20,22 .”
Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease
Wiley, C. D. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01314-y · Cited by 39
Sundar, I. K., Rashid, K., Gerloff, J., Rangel‐Moreno, J., Li, D., & Rahman, I. (2018) · The FASEB Journal · doi:10.1096/fj.201701518r · Cited by 38
Cellular senescence in ischemia/reperfusion injury
Chen, C., Zheng, M., Hou, H., Fang, S., Chen, L., Yang, J., Yao, W., Zhang, Q., & Hei, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01205-z · Cited by 45
Cellular senescence as a therapeutic target to improve renal transplantation outcome
van Willigenburg, H., de Keizer, P. L. J., & de Bruin, R. W. F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.015 · Cited by 38
Amelioration of age‐related brain function decline by Bruton's tyrosine kinase inhibition
Ekpenyong‐Akiba, A. E., Poblocka, M., Althubiti, M., Rada, M., Jurk, D., Germano, S., Kocsis‐Fodor, G., Shi, Y., Canales, J. J., & Macip, S. (2019) · Aging Cell · doi:10.1111/acel.13079 · Cited by 45
Senotherapeutics and Their Molecular Mechanism for Improving Aging
Park, J., & Shin, D. W. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.114 · Cited by 49
“Much research effort has recently been made to therapeutically target the harmful effects of cellular senescence (Baker et al., 2011, 2016; Childs et al., 2017; Krimpenfort and Berns, 2017).”
Pak2 kinase promotes cellular senescence and organismal aging
Lee, J.-S., Mo, Y., Gan, H., Burgess, R. J., Baker, D. J., van Deursen, J. M., & Zhang, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903847116 · Cited by 42
Self-citationSenescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 51
“For example, elimination of senescent cells in aged mice had no effect on glucose or insulin tolerance (Baker et al., 2016), and diabetes is not a common consequence of progerias, chemotherapies, or most HIV treatments in use today— though earlier HIV therapies were associated with diabetes…”
BackgroundDistinct senotypes in p16- and p21-positive cells across human and mouse aging tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Han, Y., Zhang, X., Franco, A. C., Kim, S. Y., Wyles, S. P., Prakash, Y. S., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00601-2 · Cited by 45
“Clearance of p16 + cells has been shown to extend median lifespan (Baker et al, 2016) while p21 + cell clearance has been recently shown to extend both median and maximum lifespan, further indicating distinct biological roles during aging (Wang et al, 2024a).”
Senescence in the aging process
Faragher, R., McArdle, A., Willows, A. O. D., & Ostler, E. L. (2017) · F1000Research · doi:10.12688/f1000research.10903.1 · Cited by 41
Miller, K. N., Li, B., Pierce-Hoffman, H. R., Patel, S., Lei, X., Rajesh, A., Teneche, M. G., Havas, A. P., Gandhi, A., Macip, C. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57229-3 · Cited by 230
Induction and transmission of oncogene-induced senescence
Rattanavirotkul, N., Kirschner, K., & Chandra, T. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03638-0 · Cited by 44
Anti‐inflammaging effects of human alpha‐1 antitrypsin
Yuan, Y., DiCiaccio, B., Li, Y., Elshikha, A. S., Titov, D., Brenner, B. R., Seifer, L., Pan, H., Karic, N., Akbar, M. A., et al. (2017) · Aging Cell · doi:10.1111/acel.12694 · Cited by 38
Possible interventions to modify aging
Libertini, G., & Ferrara, N. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916120038 · Cited by 39
The mTORC1-autophagy pathway is a target for senescent cell elimination
Kucheryavenko, O., Nelson, G., von Zglinicki, T., Korolchuk, V. I., & Carroll, B. (2019) · Biogerontology · doi:10.1007/s10522-019-09802-9 · Cited by 45
Mid-old cells are a potential target for anti-aging interventions in the elderly
Kim, Y. H., Lee, Y., Park, S. S., Park, S. H., Eom, S. Y., Lee, Y., Lee, W. J., Jang, J., Seo, D., Kang, H. Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43491-w · Cited by 47
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
Malayaperumal, S., Marotta, F., Kumar, M. M., Somasundaram, I., Ayala, A., Pinto, M. F. M., Banerjee, A., & Pathak, S. (2023) · Clinics and Practice · doi:10.3390/clinpract13040076 · Cited by 41
“In particular, a recent study found that genetically eliminating tissue-resident senescent cells substantially boosts the lifespan of mice, who also have lower cancer mortality rates [73].”
BackgroundMazzucco, A. E., Smogorzewska, A., Kang, C., Luo, J., Schlabach, M. R., Xu, Q., Patel, R., & Elledge, S. J. (2017) · Genes & Development · doi:10.1101/gad.304857.117 · Cited by 35
Barnes, P. J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_3 · Cited by 40
Age and metastasis – How age influences metastatic spread in cancer. Colorectal cancer as a model
Pretzsch, E., Nieß, H., Bösch, F., Westphalen, C. B., Jacob, S., Neumann, J. H. L., Werner, J., Heinemann, V., & Angele, M. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102112 · Cited by 41
Ni, J., Au, M. T., Kong, H., Wang, X., & Wen, C. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03385-0 · Cited by 37
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 63
Hu, L., Dong, C., Wang, Z., He, S., Yang, Y., Zi, M., Li, H., Zhang, Y., Chen, C., Zheng, R., et al. (2023) · Aging Cell · doi:10.1111/acel.13896 · Cited by 43
“Selective elimination of SnCs via transgenic or pharmaceutical strategies can treat age- related diseases and extend health span (Baker et al., 2016; Di Micco et al., 2021; Kirkland & Tchkonia, 2020; van Deursen, 2019).”
BackgroundTing, K. K., Coleman, P. R., Zhao, Y., Vadas, M. A., & Gamble, J. R. (2021) · Vascular Biology · doi:10.1530/vb-20-0013 · Cited by 43
Age-related oxidative changes in pancreatic islets are predominantly located in the vascular system
Kehm, R., König, J., Nowotny, K., Jung, T., Deubel, S., Gohlke, S., Schulz, T. J., & Höhn, A. (2017) · Redox Biology · doi:10.1016/j.redox.2017.12.015 · Cited by 46
The Role of FoxOs in Bone Health and Disease
Kim, H., Iyer, S. V., Ring, R., & Almeida, M. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.004 · Cited by 39
Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?
Cianflone, E., Torella, M., Chimenti, C., Angelis, A. D., Beltrami, A. P., Urbanek, K., Rota, M., & Torella, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5813147 · Cited by 41
SIPS as a model to study age-related changes in proteolysis and aggregate formation
Ott, C., Jung, T., Grune, T., & Höhn, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.07.007 · Cited by 44
Bravo, J. I., Nozownik, S., Danthi, P. S., & Benayoun, B. A. (2020) · Development · doi:10.1242/dev.175786 · Cited by 38
Madani, A. Y., Majeed, Y., Abdesselem, H. B., Agha, M. V., Vakayil, M., Sukhun, N. K. A., Halabi, N. M., Kumar, P., Hayat, S., Elrayess, M. A., et al. (2021) · Antioxidants · doi:10.3390/antiox10020334 · Cited by 37
Epigenetic dysregulation in cardiovascular aging and disease
Herman, A. B., Occean, J. R., & Sen, P. (2021) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2021.16 · Cited by 46
Hong, X., Wang, L., Zhang, K., Liu, J., & Liu, J. (2022) · Cells · doi:10.3390/cells11050877 · Cited by 38
Aging and the Biological Response to Liver Injury
Marzioni, M., Pinto, C., Ninfole, E., Gaggiano, L., Benedetti, A., & Maroni, L. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402033 · Cited by 36
Procyanidin B2 ameliorates the progression of osteoarthritis: An in vitro and in vivo study
Cai, W., Zhang, Y., Jin, W., Wei, S., Chen, J., Zhong, C., Zhong, Y., Tu, C., & Peng, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109336 · Cited by 44
Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
Сухих, С. А., Носкова, С., Ivanova, S. A., Ulrikh, E., Izgaryshev, A., & Babich, O. (2021) · Molecules · doi:10.3390/molecules26082391 · Cited by 43
mTOR as a senescence manipulation target: A forked road
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.002 · Cited by 35
Senescence induction universally activates transposable element expression
Colombo, A. R., Elias, H. K., & Ramsingh, G. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1502576 · Cited by 36
de Montgolfier, O., Pouliot, P., Gillis, M., Ferland, G., Lesage, F., Thorin‐Trescases, N., & Thorin, É. (2019) · GeroScience · doi:10.1007/s11357-019-00070-6 · Cited by 43
Kumar, R., Sharma, A., Padwad, Y. S., & Sharma, R. (2020) · Biogerontology · doi:10.1007/s10522-020-09861-3 · Cited by 35
Metabolic remodeling in cancer and senescence and its therapeutic implications
Kim, Y., Jang, Y., Kim, M.-S., & Kang, C. (2024) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2024.02.008 · Cited by 36
Telomeres as hotspots for innate immunity and inflammation
Nassour, J., Przetocka, S., & Karlseder, J. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103591 · Cited by 42
Advancing biological understanding of cellular senescence with computational multiomics
Li, S., Agudelo Garcia, P. A., Aliferis, C., Becich, M. J., Calyeca, J., Cosgrove, B. D., Elisseeff, J., Farzad, N., Fertig, E. J., Glass, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02314-y · Cited by 40
Self-citationCavinato, M. S., Madreiter‐Sokolowski, C. T., Büttner, S., Schosserer, M., Zwerschke, W., Wedel, S., Grillari, J., Graier, W. F., & Jansen‐Dürr, P. (2020) · FEBS Journal · doi:10.1111/febs.15631 · Cited by 41
Death-seq identifies regulators of cell death and senolytic therapies
Colville, A., Liu, J., Rodríguez-Mateo, C., Thomas, S. M., Ishak, H. D., Zhou, R., Klein, J. D. D., Morgens, D. W., Goshayeshi, A., Salvi, J. S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.08.008 · Cited by 43
The turquoise killifish: a genetically tractable model for the study of aging
Poeschla, M., & Valenzano, D. R. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.209296 · Cited by 45
Vegetables and Their Bioactive Compounds as Anti-Aging Drugs
Mechchate, H., Allam, A. E., Omari, N. E., Hachlafi, N. E., Shariati, M. A., Wilairatana, P., Mubarak, M. S., & Bouyahya, A. (2022) · Molecules · doi:10.3390/molecules27072316 · Cited by 40
Ramadhiani, R., Ikeda, K., Miyagawa, K., Ryanto, G. R. T., Tamada, N., Suzuki, Y., Kirita, Y., Matoba, S., Hirata, K., & Emoto, N. (2023) · iScience · doi:10.1016/j.isci.2023.106662 · Cited by 45
Komatsu, T., Park, S., Hayashi, H., Mori, R., Yamaza, H., & Shimokawa, I. (2019) · Nutrients · doi:10.3390/nu11123068 · Cited by 43
Immune and inflammatory responses to DNA damage in cancer and aging
Soria-Valles, C., López-Soto, A., Osorio, F. G., & López-Otín, C. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.10.004 · Cited by 36
Exosomal long noncoding RNAs in aging and age‐related diseases
Cao, Q., Guo, Z., Yan, Y., Wu, J., & Song, C. (2019) · IUBMB Life · doi:10.1002/iub.2141 · Cited by 36
Tissue engineering strategies to bioengineer the ageing skin phenotype in vitro
Costello, L., DiColandrea, T., Tasseff, R. A., Isfort, R. J., Bascom, C., von Zglinicki, T., & Przyborski, S. A. (2022) · Aging Cell · doi:10.1111/acel.13550 · Cited by 36
Yao, M., Wei, Z., Nielsen, J. S., Ouyang, Y., Kakazu, A., Wang, H., Du, L., Li, R., Chu, T., Scafidi, S., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106711 · Cited by 40
“A cocktail of two US Federal Drug Administration (FDA)- approved ‘senolytic’ compounds, dasatinib and quercetin (D + Q), can selectively eliminate senescent cells from pathological tissues (12-14), and may thereby counteract age-related pathogenic processes (15, 16).”
Diwan, B., & Sharma, R. (2022) · Food Science and Biotechnology · doi:10.1007/s10068-022-01114-y · Cited by 40
Senopathies-Diseases Associated with Cellular Senescence
Lushchak, O., Schosserer, M., & Grillari, J. (2023) · Biomolecules · doi:10.3390/biom13060966 · Cited by 35
“Ultimately, elegant experiments in mice showed that the accumulation of SCs during aging limits the healthy murine lifespan [14,15].”
BackgroundAging, metabolism and stem cells: Spotlight on muscle stem cells
García-Prat, L., & Muñoz-Cánoves, P. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.08.021 · Cited by 34
Sawaki, D., Zhang, Y., Mohamadi, A., Pini, M., Mezdari, Z., Lipskaia, L., Naushad, S., Lamendour, L., Altintas, D. M., Breau, M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.145811 · Cited by 41
Ungvari, A., Gulej, R., Csík, B., Mukli, P., Negri, S., Tarantini, S., Yabluchanskiy, A., Benyó, Z., Csiszár, A., & Ungvari, Z. I. (2023) · Nutrients · doi:10.3390/nu15214662 · Cited by 39
Gadecka, A., Nowak, N., Bulanda, E., Janiszewska, D., Dudkowska, M., Sikora, E., & Bielak-Żmijewska, A. (2025) · GeroScience · doi:10.1007/s11357-024-01504-6 · Cited by 42
“Ever since it has been proven that cellular senescence is directly responsible for age-related health problems, senescent cells have been recognized as a potential therapeutic target to alleviate the symptoms of aging [1, 2].”
Senotherapy: growing old and staying young?
Schmitt, R. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1972-4 · Cited by 37
Role of autophagy in lung diseases and ageing
Zhang, Y., Zhang, J., & Fu, Z. (2022) · European Respiratory Review · doi:10.1183/16000617.0134-2022 · Cited by 42
The aged liver: Beyond cellular senescence
Allaire, M., & Gilgenkrantz, H. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.07.011 · Cited by 41
Organ-differential Roles of Akt/FoxOs Axis as a Key Metabolic Modulator during Aging
Kim, D. H., Bang, E., Ha, S., Jung, H. J., Choi, Y. J., Yu, B. P., & Chung, H. Y. (2021) · Aging and Disease · doi:10.14336/ad.2021.0225 · Cited by 40
Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
Manakanatas, C., Ghadge, S. K., Agic, A., Sarigol, F., Fichtinger, P., Fischer, I., Foisner, R., & Osmanagic‐Myers, S. (2022) · Aging · doi:10.18632/aging.203820 · Cited by 38
Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients
Al-Danakh, A., Safi, M., Jian, Y., Yang, L., Zhu, X., Chen, Q., Yang, K., Wang, S., Zhang, J., & Yang, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1348189 · Cited by 39
Mitotic Dysfunction Associated with Aging Hallmarks
Macedo, J. C., Vaz, S., & Logarinho, E. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57127-0_7 · Cited by 42
Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development
Devulder, J. V. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2024.08.007 · Cited by 47
“132 , 133 Senolytics are small molecules that eliminate senescent cells by inducing apoptosis.”
BackgroundTreating age-related multimorbidity: the drug discovery challenge
Ermogenous, C., Green, C., Jackson, T., Ferguson, M. A. J., & Lord, J. M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.06.016 · Cited by 39
The Molecular Intersection Between Senescence and Major Depression in the Elderly
Diniz, B. S. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.07.005 · Cited by 39
Gonadal sex patterns p21-induced cellular senescence in mouse and human glioblastoma
Broestl, L., Warrington, N. M., Grandison, L., Abou-Antoun, T., Tung, O., Shenoy, S., Tallman, M. M., Rhee, G., Yang, W., Sponagel, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03743-9 · Cited by 42
Alcalde-Estévez, E., Asenjo-Bueno, A., Sosa, P., Olmos, G., Plaza, P., Caballero-Mora, M. Á., Rodríguez-Puyol, D., Ruíz-Torres, M. P., & López-Ongil, S. (2020) · Aging · doi:10.18632/aging.103450 · Cited by 35
“aged-related diseases [54, 55], where the presence of senescent cells within a tissue was related to the loss of function, and treatment lead to remove senescent cells from tissues improved the organ function.”
BackgroundSpurious intragenic transcription is a feature of mammalian cellular senescence and tissue aging
Sen, P., Donahue, G., Li, C. Y., Egervári, G., Yang, N., Lan, Y., Robertson, N., Shah, P. P., Kerkhoven, E., Schultz, D., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00384-3 · Cited by 40
Cellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K. U., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 43
Cellular senescence and senescence‐associated T cells as a potential therapeutic target
Nakagami, H. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13851 · Cited by 35
Autophagy inhibition signals through senescence to promote tumor suppression
Peng, N., Kang, H. H., Feng, Y., Minikes, A. M., & Jiang, X. (2022) · Autophagy · doi:10.1080/15548627.2022.2155794 · Cited by 39
A BDNF-TrkB autocrine loop enhances senescent cell viability
Anerillas, C., Herman, A. B., Munk, R., Garrido, A., Lam, K.-W. G., Payea, M. J., Rossi, M., Tsitsipatis, D., Martindale, J. L., Piao, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33709-8 · Cited by 35
An overview of contemporary theories of ageing
de Magalhães, J. P. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01698-7 · Cited by 53
“Senescent cells have been shown to have detrimental effects 56 , and their genetic removal reduces signs of ageing and extends lifespan in mice 57 , although other studies have produced conflicting results 58–61 .”
IL-23R is a senescence-linked circulating and tissue biomarker of aging
Carver, C. M., Rodriguez, S. L., Atkinson, E. J., Dosch, A. J., Asmussen, N. C., Gomez, P. T., Leitschuh, E. A., Espíndola‐Netto, J. M., Jeganathan, K. B., Whaley, M. G., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00752-7 · Cited by 43
“Previous p16-InkAttac targeting of p16 -positive cells through long-term treatment with AP denoted clearance in a variable and tissue-specific manner, with substantial effects in kidney 26 .”
Self-citationKatsuumi, G., Shimizu, I., Yoshida, Y., Hayashi, Y., Ikegami, R., Suda, M., Wakasugi, T., Nakao, M., & Minamino, T. (2018) · International Heart Journal · doi:10.1536/ihj.17-313 · Cited by 34
To target cellular senescence in diabetic kidney disease: the known and the unknown
Wei, Y., Mou, S., Yang, Q., Liu, F., Cooper, M. E., & Chai, Z. (2024) · Clinical Science · doi:10.1042/cs20240717 · Cited by 45
“Taken together, these studies show that increased accumulation of senescent cells is associated with inflammation and fibrosis as well as the consequent loss of renal function in the diabetic kidney [37,79,148].”
BackgroundMeasuring Biologic Resilience in Older Cancer Survivors
Sedrak, M. S., Gilmore, N. J., Carroll, J. E., Muss, H. B., Cohen, H. J., & Dale, W. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00245 · Cited by 39
Wang, H., Karuppan, M. K. M., Devadoss, D., Nair, M., Chand, H. S., & Lakshmana, M. K. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.003 · Cited by 38
Khatiwala, R. V., Zhang, S., Li, X., Devejian, N. S., Bennett, E. V., & Cai, C. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9815-z · Cited by 38
Harries, L. (2022) · The FEBS Journal · doi:10.1111/febs.16462 · Cited by 33
Slowing down as we age: aging of the cardiac pacemaker’s neural control
Choi, S., Baudot, M., Vivas, O., & Moreno, C. M. (2021) · GeroScience · doi:10.1007/s11357-021-00420-3 · Cited by 36
In vivo reprogramming for tissue regeneration and organismal rejuvenation
Taguchi, J., & Yamada, Y. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.008 · Cited by 35
Context‐dependent roles of cellular senescence in normal, aged, and disease states
Moiseeva, V., Cisneros, A., Cobos, A. C., Tarrega, A. B., Oñate, C. S., Perdiguero, E., Serrano, A. L., & Muñoz‐Cánoves, P. (2023) · The FEBS Journal · doi:10.1111/febs.16573 · Cited by 34
Role of cellular senescence in inflammatory lung diseases
Xie, C. H., Yalikun, M., Luo, Q., & Dong, J. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.02.001 · Cited by 33
Integrating integrins with the hallmarks of cancer
Haake, S. M., Rios, B. L., Pozzi, A., & Zent, R. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.04.003 · Cited by 46
Haarer, E. L., Theodore, C. J., Guo, S., Frier, R. B., & Campellone, K. G. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010045 · Cited by 40
Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy
Jiang, B., Zhang, W., Zhang, X., & Sun, Y. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.002 · Cited by 39
Current Understanding of the Role of Senescent Melanocytes in Skin Ageing
Hughes, B. K., & Bishop, C. L. (2022) · Biomedicines · doi:10.3390/biomedicines10123111 · Cited by 42
“Seminal research from the Van Deursen group detected that selective clearance of p16positive cells in aged rodents improved several age-related diseases, and increased rodent lifespan [36,37].”
BackgroundRare progerin-expressing preadipocytes and adipocytes contribute to tissue depletion over time
Revêchon, G., Viceconte, N., McKenna, T., Sola-Carvajal, A., Vrtačnik, P., Stenvinkel, P., Lundgren, T., Hultenby, K. R., Franco, I., & Eriksson, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04492-0 · Cited by 38
Early growth response 2 (EGR2) is a novel regulator of the senescence programme
Tyler, E. J., del Arroyo, A. G., Wallis, R., Hughes, B., Garbe, J. C., Stampfer, M. R., Koh, J., Lowe, R., Philpott, M. P., & Bishop, C. L. (2021) · Aging Cell · doi:10.1111/acel.13318 · Cited by 38
Serebryannyy, L., & Misteli, T. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201706061 · Cited by 39
Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules
Heiß, C., Spyridopoulos, I., & Haendeler, J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.015 · Cited by 40
Wang, J., Lu, Y., Carr, C., Dhandapani, K. M., & Brann, D. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1227705 · Cited by 44
Marques, L., Johnson, A. A., & Stolzing, A. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112203 · Cited by 34
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.